Prof. dr. Esther WOLFS

+3211269296 Campus Diepenbeek
Gebouw C
Office BMO-C012

Prof. dr. Esther WOLFS

Associate Professor

Faculty of Medicine and Life Sciences
Capacity group Cardio & organ systems
Research group Cardio & organ systems
Biomedical Research Institute

Research

Discipline codes: Nuclear imaging (03061804), Medical imaging and therapy not elsewhere classified (03061899), Cell therapy (03063201), Neurological and neuromuscular diseases (03062305), Cancer therapy (03062405)

Supervised PhDs

From Experimental Models to Targeted Therapies for Oral Squamous Cell Carcinoma.

Jolien Van den Bosch for the title Doctor of Biomedical Sciences (doctorate in progress)

Supervised as Promotor

IGF-2 and [DES-1-6]IGF-2 as new tools to boost neurogenesis after ischemic stroke.

Lotte Alders for the title Doctor of Biomedical Sciences (doctorate in progress)

Supervised as Copromotor

Future proof pathology for predictive medicine and disease prognosis based on tumor heterogeneity

Kim Nijsten for the title Doctor of Biomedical Sciences (doctorate in progress)

Supervised as Promotor

Quantifying and modeling spatial heterogeneity within the lung tumor microenvironment

Jari Claes for the title Doctor of Sciences: Statistics (doctorate in progress)

Supervised as Copromotor

Future proof pathology for predictive medicine and disease prognosis based on tumor heterogeneity.

Melvin Geubbelmans for the title Doctor of Sciences: Statistics (doctorate in progress)

Supervised as Copromotor

View all 13 supervised PhD's of Prof. dr. Esther WOLFS

The molecular hug between the ER and mitochondria in Charcot-Marie-Tooth disease type 1A

Hanne Jeurissen for the title Doctor of Biomedical Sciences (doctorate in progress)

Supervised as Promotor

An innovative nanocarrier-based drug delivery system to treat head and neck squamous cell carcinoma

Nuran Caz for the title Doctor of Biomedical Sciences (doctorate in progress)

Supervised as Promotor

Charcot-Marie-Tooth disease type 1A: a traffic jam at the Kennedy tunnel

Koen Kuipers for the title Doctor of Biomedical Sciences (doctorate in progress)

Supervised as Copromotor

Human dental pulp stem cells as a patient-in-a-dish model for Charcot-Marie-Tooth disease type 1A

Nathalie Dirkx for the title Doctor of Biomedical Sciences (doctorate in progress)

Supervised as Promotor

Advancing precision oncology: Plasma-treated hydrogels as a targeted therapy for head and neck cancer

Thomas Raps for the title Doctor of Biomedical Sciences (doctorate in progress)

Supervised as Promotor

Doxorubicin-induced cardiotoxicity: pyridoxamine to the rescue?

Sibren Haesen for the title Doctor of Biomedical Sciences in 2024

Supervised as Copromotor

Unraveling CMT1A: Models, Mechanisms, and Therapeutic Approaches

Karen Libberecht for the title Doctor of Biomedical Sciences in 2024

Supervised as Promotor

Human dental pulp stem cell-mediated mechanisms of neuroregeneration and optimization of the transient middle cerebral artery occlusion mouse stroke model

Pascal Gervois for the title Doctor of Biomedical Sciences in 2017

Supervised as Copromotor

View all 13 supervised PhD's of Prof. dr. Esther WOLFS

Publications

View all UHasselt publications by Prof. dr. Esther WOLFS

Projects

32 research projects have been found

View all 32 UHasselt research projects of Prof. dr. Esther WOLFS

Plasma-treated hydrogels as a new selective therapy for head and neck cancer (Research)

01/01/2024 - 31/12/2027

Disturbances in Phospholipid Turnover in Charcot-Marie-Tooth disease Type 1A (Research)

01/11/2023 - 30/12/2027

Squeezing Cancer: Micro-Topographies to Decode Biological Pathways for Targeted HNSCC Therapeutics (Research)

01/10/2024 - 30/09/2027

Digital Pathology Innovations in Cross-Border Connectivity, AI and Mass Spectrometry (Research)

01/09/2024 - 31/08/2027

Creation of a humanized mouse model for demyelinating peripheral neuropathies as a platform for therapeutic testing. (Research)

01/01/2023 - 31/12/2026

Human dental pulp stem cells as a patient-in-a-dish model for Charcot-Marie-Tooth disease type 1A (Research)

01/11/2022 - 31/10/2026

Human dental pulp stem cells as a patient-in-a-dish model for Charcot-Marie-Tooth disease type 1A (Research)

01/11/2022 - 31/10/2026

Charcot-Marie-Tooth Disease Type 1A: Traffic jam at the Kennedy Tunnel. (Research)

01/11/2022 - 31/10/2026

Digital microscopy in future education (Education)

01/09/2022 - 31/12/2025

The molecular hug between the ER and mitochondria in Charcot- Marie-Tooth disease type 1A (Research)

01/11/2023 - 31/10/2025

IGF-2 and Des(1-6)IGF-2 as new tools to boost neurogenesis after ischemic stroke. (Research)

01/11/2023 - 31/10/2025

The molecular hug between the ER and mitochondria in Charcot- Marie-Tooth disease type 1A (Research)

01/11/2021 - 31/10/2025

NEED - Bioresponsive nanocarriers as a therapy for cancer and wound healing. (Research)

01/01/2021 - 31/12/2024

Future proof pathology for predictive medicine and disease prognosis based on tumor heterogeneity. (Research)

01/01/2021 - 31/12/2024

From Onco to Cardio: AGEs as a new target for chemotherapyinduced cardiotoxicity. (Research)

01/11/2022 - 31/10/2024

Creation of a humanized mouse model for Charcot Marie Tooth disease type 1A (Research)

01/10/2023 - 30/09/2024

Development of a new CMT1A research toolbox: an alternative human stem cell-based strategy (Research)

01/01/2022 - 31/05/2024

The next generation of transmission electron microscopy: from biomedicine to nanomaterials. A state-of-the art electron microscopy system for cryo-EM and correlative light and electron microscopy. (Research)

01/05/2020 - 30/04/2024

Dental stem cells as effective vehicles in a new therapy for oral squamous cell carcinoma. (Research)

01/01/2020 - 31/12/2023

The molecular hug between the ER and mitochondria in Charcot- Marie-Tooth disease type 1A (Research)

01/11/2021 - 31/10/2023

IGF-2 and Des [1-6] IGF-2 as new tools to boost neurogenesis after ischemic stroke. (Research)

01/11/2021 - 31/10/2023

Protein misfolding in Charcot-Marie-Tooth disease type 1A: opening the gates for cathepsin B and peripheral nerve demyelination. (Research)

01/11/2021 - 31/10/2023

IGF-2 and [DES-1-6]IGF-2 as new tools to boost neurogenesis after ischemic stroke (Research)

01/11/2020 - 31/10/2023

Protein misfolding in Charcot-Marie-Tooth disease type 1A: opening the gates for cathepsin B and peripheral nerve demyelination. (Research)

01/11/2019 - 31/10/2023

Charcot-Marie-Tooth disease, peripheral myelin protein 22, Schwann cells, dental pulp stem cells, induced pluripotent stem cells (Research)

01/10/2019 - 30/09/2023

Suicide gene therapy as a new treatment for oral squamous cell carcinoma: a dental stem cell-based approach. (Research)

01/10/2019 - 30/09/2023

From Onco to Cardio: AGEs as a new target for chemotherapyinduced cardiotoxicity. (Research)

01/11/2020 - 31/10/2022

Protein misfolding in Charcot-Marie-Tooth disease type 1A: opening the gates for cathepsin B and peripheral nerve demyelination. (Research)

01/11/2019 - 31/10/2021

GMP Booster: the cell and gene therapy pilot plant (Research)

01/05/2020 - 30/04/2021

Chemotherapy-induced cardiotoxicity: time for a chAnGE of stRAteGiEs. (Research)

01/11/2019 - 31/10/2020

ATMP Center: custom quality control & GMP services for clinical ATMP development (Research)

01/05/2019 - 30/04/2020

Neuroprotective and neuroregenerative effects of transplantation of neurotrophic enhanced dental pulp stem cells in ischaemic stroke. (Research)

01/10/2018 - 07/09/2019

View all 32 UHasselt research projects of Prof. dr. Esther WOLFS

Education

Involved in the following courses

Academic year 2024 - 2025

3610

Biomedical neurosciences

Coordinating lecturer

1862

Dissection

Coordinating lecturer

3950

Experimental Design in Molecular Mechanisms in Health and Disease

Member of the teaching team

3607

Functional anatomy

Coordinating lecturer

3951

Innovative techniques in imaging

Member of the teaching team

4101

Neuroscience

Member of the teaching team

3978

Regenerative medicine

Co-lecturer

4606

Internship and electives

Member of the teaching team

Academic year 2023 - 2024

3610

Biomedical neurosciences

Coordinating lecturer

3627

Pathology of the cell

Member of the teaching team

1862

Dissection

Coordinating lecturer

3950

Experimental Design in Molecular Mechanisms in Health and Disease

Member of the teaching team

3607

Functional anatomy

Coordinating lecturer

3951

Innovative techniques in imaging

Member of the teaching team

4101

Neuroscience

Member of the teaching team

3978

Regenerative medicine

Co-lecturer

4606

Internship and electives

Member of the teaching team

Esther WOLFS

E-mail:

E-mail Esther

Phone:

+3211269296

Location:

Campus Diepenbeek
Gebouw C
Office BMO-C012

Are you Esther WOLFS? Log in to edit this page

Prof. dr. Esther WOLFS

Research

Supervised PhDs

From Experimental Models to Targeted Therapies for Oral Squamous Cell Carcinoma.

IGF-2 and [DES-1-6]IGF-2 as new tools to boost neurogenesis after ischemic stroke.

Future proof pathology for predictive medicine and disease prognosis based on tumor heterogeneity

Quantifying and modeling spatial heterogeneity within the lung tumor microenvironment

Future proof pathology for predictive medicine and disease prognosis based on tumor heterogeneity.

The molecular hug between the ER and mitochondria in Charcot-Marie-Tooth disease type 1A

An innovative nanocarrier-based drug delivery system to treat head and neck squamous cell carcinoma

Charcot-Marie-Tooth disease type 1A: a traffic jam at the Kennedy tunnel

Human dental pulp stem cells as a patient-in-a-dish model for Charcot-Marie-Tooth disease type 1A

Advancing precision oncology: Plasma-treated hydrogels as a targeted therapy for head and neck cancer

Doxorubicin-induced cardiotoxicity: pyridoxamine to the rescue?

Unraveling CMT1A: Models, Mechanisms, and Therapeutic Approaches

Human dental pulp stem cell-mediated mechanisms of neuroregeneration and optimization of the transient middle cerebral artery occlusion mouse stroke model

Publications

Projects

Plasma-treated hydrogels as a new selective therapy for head and neck cancer (Research)

Disturbances in Phospholipid Turnover in Charcot-Marie-Tooth disease Type 1A (Research)

Squeezing Cancer: Micro-Topographies to Decode Biological Pathways for Targeted HNSCC Therapeutics (Research)

Digital Pathology Innovations in Cross-Border Connectivity, AI and Mass Spectrometry (Research)

Creation of a humanized mouse model for demyelinating peripheral neuropathies as a platform for therapeutic testing. (Research)

Human dental pulp stem cells as a patient-in-a-dish model for Charcot-Marie-Tooth disease type 1A (Research)

Human dental pulp stem cells as a patient-in-a-dish model for Charcot-Marie-Tooth disease type 1A (Research)

Charcot-Marie-Tooth Disease Type 1A: Traffic jam at the Kennedy Tunnel. (Research)

Digital microscopy in future education (Education)

The molecular hug between the ER and mitochondria in Charcot- Marie-Tooth disease type 1A (Research)

IGF-2 and Des(1-6)IGF-2 as new tools to boost neurogenesis after ischemic stroke. (Research)

The molecular hug between the ER and mitochondria in Charcot- Marie-Tooth disease type 1A (Research)

NEED - Bioresponsive nanocarriers as a therapy for cancer and wound healing. (Research)

Future proof pathology for predictive medicine and disease prognosis based on tumor heterogeneity. (Research)

From Onco to Cardio: AGEs as a new target for chemotherapyinduced cardiotoxicity. (Research)

Creation of a humanized mouse model for Charcot Marie Tooth disease type 1A (Research)

Development of a new CMT1A research toolbox: an alternative human stem cell-based strategy (Research)

The next generation of transmission electron microscopy: from biomedicine to nanomaterials. A state-of-the art electron microscopy system for cryo-EM and correlative light and electron microscopy. (Research)

Dental stem cells as effective vehicles in a new therapy for oral squamous cell carcinoma. (Research)

The molecular hug between the ER and mitochondria in Charcot- Marie-Tooth disease type 1A (Research)

IGF-2 and Des [1-6] IGF-2 as new tools to boost neurogenesis after ischemic stroke. (Research)

Protein misfolding in Charcot-Marie-Tooth disease type 1A: opening the gates for cathepsin B and peripheral nerve demyelination. (Research)

IGF-2 and [DES-1-6]IGF-2 as new tools to boost neurogenesis after ischemic stroke (Research)

Protein misfolding in Charcot-Marie-Tooth disease type 1A: opening the gates for cathepsin B and peripheral nerve demyelination. (Research)

Charcot-Marie-Tooth disease, peripheral myelin protein 22, Schwann cells, dental pulp stem cells, induced pluripotent stem cells (Research)

Suicide gene therapy as a new treatment for oral squamous cell carcinoma: a dental stem cell-based approach. (Research)

From Onco to Cardio: AGEs as a new target for chemotherapyinduced cardiotoxicity. (Research)

Protein misfolding in Charcot-Marie-Tooth disease type 1A: opening the gates for cathepsin B and peripheral nerve demyelination. (Research)

GMP Booster: the cell and gene therapy pilot plant (Research)

Chemotherapy-induced cardiotoxicity: time for a chAnGE of stRAteGiEs. (Research)

ATMP Center: custom quality control & GMP services for clinical ATMP development (Research)

Neuroprotective and neuroregenerative effects of transplantation of neurotrophic enhanced dental pulp stem cells in ischaemic stroke. (Research)

Education

Involved in the following courses

Academic year 2024 - 2025

Biomedical neurosciences

Dissection

Experimental Design in Molecular Mechanisms in Health and Disease

Functional anatomy

Innovative techniques in imaging

Neuroscience

Regenerative medicine

Internship and electives

Academic year 2023 - 2024

Biomedical neurosciences

Pathology of the cell

Dissection

Experimental Design in Molecular Mechanisms in Health and Disease

Functional anatomy

Innovative techniques in imaging

Neuroscience

Regenerative medicine

Internship and electives

Esther WOLFS

Follow

Information for

Programmes

Hasselt University

Tools

Social Media